Veronika Bouskova | Molecular Biology | Best Researcher Award

Dr. Veronika Bouskova | Molecular Biology | Best Researcher Award

Young scientist from Biomedical Centre in Pilsen, Czech Republic.

Dr. Veronika Boušková (née Brynychová) is a distinguished Czech researcher in the field of molecular biology and pharmacogenomics, with a particular focus on breast cancer biology and genetic variability. Her career combines academic research, laboratory-based investigation, and mentoring of young scientists. With a Ph.D. from the Third Faculty of Medicine at Charles University and over a decade of experience at premier research institutions like the Biomedical Center of the Faculty of Medicine in Pilsen and the National Institute of Public Health in Prague, she has established herself as a leading expert in transcriptomic analysis, caspase signaling, and the clinical implications of genetic variants in cancer prognosis and treatment. Dr. Boušková has authored or co-authored numerous articles published in high-impact journals and holds an impressive h-index of 13. Her research is notable for its integrative approach, combining molecular, cellular, and genetic data to better understand cancer progression and therapy resistance. She is also actively involved in academic education and mentoring, guiding the next generation of scientists. Her ability to conduct interdisciplinary research and her contributions to clinical and translational oncology make her a strong candidate for recognition through research awards.

Professional Profile

Education

Dr. Boušková has pursued a rigorous and interdisciplinary educational path rooted in biological sciences. She earned her Bachelor’s degree in Biology from the Faculty of Science at Charles University in 2008, followed by a Master’s degree in Biology, which she completed in 2010 through a collaborative program involving the Department of Anthropology and Human Genetics and the Institute of Archaeology at the Academy of Sciences. Her education culminated in a Ph.D. in Molecular and Cell Biology, Genetics, and Virology from the Third Faculty of Medicine, Charles University, which she pursued from 2010 to 2018. Her doctoral studies provided her with a comprehensive understanding of molecular and cellular mechanisms involved in human diseases, with a particular emphasis on cancer genetics and apoptosis. This strong educational foundation, grounded in both human genetics and molecular medicine, has enabled her to bridge basic scientific research with clinical applications. Additionally, Dr. Boušková’s involvement in interdisciplinary and international study programs reflects her commitment to continuous academic and professional growth, and has enriched her scientific perspective with cultural and methodological diversity.

Professional Experience

Dr. Boušková’s professional journey reflects her long-standing commitment to biomedical research and her evolving expertise in oncology-related molecular genetics. Since 2013, she has served as a Junior Researcher at the Biomedical Center, Faculty of Medicine in Pilsen, Charles University, where she works in the Laboratory of Pharmacogenomics. Simultaneously, she has maintained a research position at the National Institute of Public Health in Prague since 2010. Her work across both institutions focuses on investigating genetic variability, apoptosis-related genes, and microRNA expression in cancer patients, especially those with breast carcinoma. Between August 2019 and January 2022, she was on maternity leave, after which she resumed her scientific endeavors. Dr. Boušková has also been actively involved in teaching since 2015, conducting practical courses in biochemical laboratory techniques at the Faculty of Science, Charles University. She has mentored and consulted graduate students, contributing to their academic development and research projects. Her dual roles in research and education reflect a well-rounded professional profile combining laboratory excellence, mentorship, and scientific publication. Her sustained engagement in public health-oriented molecular research illustrates her commitment to improving healthcare outcomes through advanced biomedical science.

Research Interests

Dr. Veronika Boušková’s research interests center on the molecular and genetic mechanisms underlying cancer development and progression, with a particular emphasis on breast carcinoma. Her work delves into the regulation of apoptosis, the role of caspases and their isoforms, transcriptomic alterations, and microRNA expression profiles in tumor cells. She is especially interested in the pharmacogenomic implications of genetic variability, including single nucleotide polymorphisms and gene expression regulation that influence cancer prognosis and therapy response. Her integrative research also covers transcript and protein expression of genes involved in cell cycle control, epithelial-mesenchymal transition, and multidrug resistance. Additionally, Dr. Boušková has explored the impact of epigenetic modifications and miRNA-mediated gene regulation in breast cancer subtypes. Her interdisciplinary approach, combining molecular biology, genetics, pharmacology, and bioinformatics, contributes to identifying potential therapeutic targets and predictive biomarkers. She is committed to translational research, bridging laboratory findings with clinical practice to enhance personalized medicine strategies in oncology. Her recent publications reflect ongoing investigations into breast cancer microenvironment signaling, resistance mechanisms, and molecular diagnostics, demonstrating her ability to stay at the forefront of contemporary cancer research.

Research Skills

Dr. Boušková possesses a broad and advanced skill set in molecular biology and cancer genomics, honed over years of hands-on laboratory experience. Her research skills include gene expression analysis using RT-qPCR, microarray profiling, RNA sequencing, and high-resolution melting analysis. She is proficient in DNA/RNA extraction, reverse transcription, genotyping, and bioinformatics tools for analyzing transcriptomic and genomic datasets. Dr. Boušková is also skilled in cell culture techniques, protein expression studies, and functional assays relevant to apoptosis and cell signaling pathways. Her expertise extends to microRNA analysis and the use of pathway prediction software for understanding gene regulation networks. Moreover, she is well-versed in data interpretation, manuscript preparation, and collaborative research processes, contributing meaningfully to multidisciplinary teams. Her methodological rigor is evident from her contributions to over 25 peer-reviewed publications, many in high-impact journals. Additionally, she has experience in research project planning, laboratory management, and supervising student projects. Her continuous engagement with modern experimental technologies and analytical software ensures her research remains current and impactful. Her technical proficiency, analytical mindset, and collaborative approach make her a valuable contributor to complex research initiatives.

Awards and Honors

Dr. Boušková’s career includes several academic and research achievements, reflecting her dedication to high-quality scientific work. Notably, she was the recipient of a research grant from the Charles University Grant Agency (GAUK) from 2013 to 2015 for her project on the significance of apoptotic caspases and their splice variants in breast carcinoma. The project was successfully evaluated with all objectives fulfilled, highlighting her ability to manage and complete competitive research funding initiatives. Furthermore, she was awarded an internship opportunity in May 2014 at the National Research Institute of Chinese Medicine, under Dr. Yune-Fang Ueng’s laboratory, indicating her proactive pursuit of international research exposure. While there are no listings of specific awards such as national medals or society fellowships, her consistent record of high-impact publications, a strong citation index, and an h-index of 13 represent substantial academic honors in themselves. Her mentoring of graduate students and teaching contributions also reflect recognition within academic circles. Dr. Boušková’s recognition comes primarily through peer-reviewed scientific contributions and successful grant acquisitions, both of which underscore her qualifications for further accolades like the Best Researcher Award.

Conclusion

Dr. Veronika Boušková exemplifies the qualities of a top-tier biomedical researcher with a career marked by academic excellence, impactful research, and active mentorship. Her scientific focus on breast cancer genomics, microRNA regulation, and pharmacogenomics addresses some of the most pressing challenges in oncology today. With a strong publication record, an h-index of 13, and sustained research activity at reputable institutions, she has demonstrated not only productivity but also relevance and innovation in her field. Her interdisciplinary education and global research exposure further enhance her ability to navigate complex scientific questions. While expanding her international collaborations and taking on larger leadership roles in research consortia could elevate her profile further, her current contributions already reflect a researcher of significant merit and potential. Her dual commitment to research and education positions her as an influential figure within both academic and clinical research landscapes. In light of her qualifications, Dr. Boušková is highly deserving of recognition through awards such as the Best Researcher Award, which would not only honor her achievements but also support her future research endeavors aimed at improving cancer diagnosis and treatment.

Publications Top Notes

  1. Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer
    Authors: Petr Holý, Veronika Brynychová, Karolína Šeborová, Vojtěch Haničinec, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Pavel Souček, et al.
    Journal: Molecular Oncology
    Year: 2023
    Citations: 3
  2. Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer
    Authors: Ivona Krus, Veronika Brynychová, Viktor Hlaváč, Radka Václavíková, Maria Kováčová, Renata Koževnikovová, Kateřina Kopečková, Jannis Tornikidis, David Vrána, Jiří Gatěk, Pavel Souček
    Journal: Molecular Diagnosis and Therapy
    Year: 2022
    Citations: 2

 

Nazneen Naher Islam | Molecular Biology | Best Researcher Award

Prof. Dr. Nazneen Naher Islam | Molecular Biology | Best Researcher Award

Professor from Department of Genetic Engineering and Biotechnology, University of Chittagong, Bangladesh

Prof. Dr. Nazneen Naher Islam is an accomplished researcher and academic with a distinguished career in microbial genetics, genetic disorders, and molecular pathogenesis. She currently serves as Professor and Chairman of the Department of Genetic Engineering and Biotechnology at the University of Chittagong, Bangladesh. Her academic journey is marked by a strong international background, having completed her Ph.D. in Microbial Protein Engineering at Osaka City University, Japan. Dr. Islam’s work focuses extensively on genetic mutations, the molecular basis of diseases, microbial metabolite screening, and antibiotic resistance, which are highly relevant to public health concerns in Bangladesh and beyond. She has published numerous research articles in national and international journals and has contributed significantly to conference proceedings. Her leadership extends beyond research as she has successfully supervised 35 graduate students and actively teaches advanced courses in genetics and biotechnology. Dr. Islam has received several prestigious awards and scholarships throughout her academic career, reflecting her dedication and scientific excellence. Her professional affiliations with international and national microbiology and biotechnology societies further illustrate her active role in the scientific community. Prof. Dr. Nazneen Naher Islam’s academic contributions, research leadership, and dedication to mentoring the next generation of scientists make her a standout figure in her field.

Professional Profile

Education

Prof. Dr. Nazneen Naher Islam’s educational background showcases her progression through rigorous scientific training and specialization. She earned her Ph.D. in Microbial Protein Engineering from Osaka City University, Japan, between 2004 and 2008. Her doctoral research focused on the synthesis and degradation of acyl peptides by ATP and CoA-independent N-myristoyltransferase enzymes derived from Pseudomonas aeruginosa and Escherichia coli. This work laid the foundation for her later contributions to microbial genetics and biotechnology. Prior to her doctoral studies, Dr. Islam completed both her Bachelor of Science and Master of Science degrees in Botany at the University of Chittagong, Bangladesh. Her master’s research concentrated on microbial enzymes, where she graduated with First Class distinction. She completed her Higher Secondary Certificate and Secondary School Certificate from the Board of Intermediate and Secondary Education, Comilla, securing First Division results in both examinations. Her educational journey not only reflects academic excellence but also demonstrates her early commitment to the biological sciences. The blend of local and international education has uniquely positioned her to lead complex research projects that address both national health priorities and global scientific challenges.

Professional Experience

Prof. Dr. Nazneen Naher Islam has built an impressive professional career as a professor, researcher, and leader at the University of Chittagong, where she currently serves as Professor and Chairman of the Department of Genetic Engineering and Biotechnology. Over the years, she has gained extensive experience in leading multidisciplinary research teams and supervising graduate-level research. Her professional journey includes teaching specialized subjects such as microbial genetics, cytogenetics, pharmaceutical biotechnology, recombinant DNA technology, and industrial biotechnology. In addition to her academic roles, Dr. Islam has been involved in significant institutional responsibilities, including past service as a house tutor and member of the Teachers Association at Chittagong University. She has also worked as a reviewer for several national and international journals, ensuring the quality and rigor of scientific publications. Her research portfolio features numerous externally funded projects, particularly from the University Grants Commission of Bangladesh, where she has led studies on genetic mutations, microbial resistance, and public health microbiology. Throughout her career, she has demonstrated a strong commitment to advancing the fields of microbial genetics and public health while nurturing the academic growth of her students and contributing actively to the scientific community.

Research Interest

Prof. Dr. Nazneen Naher Islam’s research interests are deeply rooted in microbial genetics, genetic diseases, and the molecular mechanisms of disease development. She focuses on the prevalence and mutation spectrum of genetic disorders within the Bangladeshi population, including studies on beta-thalassemia and other inherited diseases. Dr. Islam is also passionate about exploring the molecular pathogenesis and genomics of genetic diseases, aiming to uncover the biological underpinnings that can lead to improved diagnostic and therapeutic strategies. Another significant area of her research involves the screening, molecular characterization, and industrial application of microbial secondary metabolites, which hold potential in the pharmaceutical and biotechnological industries. Her work also addresses pressing public health issues, such as antibiotic resistance, microbial contamination in food, and transmission of drug-resistant pathogens. She is particularly interested in the application of molecular biology techniques, such as PCR-based diagnostics, in improving disease detection and management. Dr. Islam’s research is both applied and translational, with a focus on generating solutions that are locally relevant and globally significant. Her wide-ranging interests enable her to contribute to the intersection of genetics, microbiology, and public health, making her research impactful on both scientific and societal levels.

Research Skills

Prof. Dr. Nazneen Naher Islam possesses a robust set of research skills that position her as a leading scientist in the fields of microbial genetics and biotechnology. She is highly proficient in molecular biology techniques, including PCR, RT-PCR, plasmid profiling, gene mutation analysis, and molecular characterization of microbes. Her expertise extends to the purification and biochemical characterization of enzymes, particularly microbial enzymes with potential industrial applications. Dr. Islam is also skilled in antimicrobial susceptibility testing, which is essential for monitoring drug resistance patterns. Her ability to conduct metagenomic studies and comparative analyses of gut microbiota further enhances her multidisciplinary research capabilities. She is well-versed in public health microbiology, particularly in the detection and molecular typing of foodborne and waterborne pathogens such as Salmonella typhi, Staphylococcus aureus, and Vibrio cholerae. Additionally, Dr. Islam’s experience in supervising graduate students has refined her project management, experimental design, and scientific communication skills. Her involvement in collaborative and independently funded research projects demonstrates her capacity for grant writing, research planning, and data analysis. Altogether, her comprehensive research skill set supports her ability to address complex scientific questions and contribute meaningfully to advancements in microbial and genetic research.

Awards and Honors

Prof. Dr. Nazneen Naher Islam has been the recipient of several prestigious awards and honors throughout her academic and research career, reflecting her scientific excellence and leadership. She was awarded the National Scholarship for Foreign Students by Osaka City University in 2008, which recognized her outstanding academic performance and research contributions during her Ph.D. studies. Between 2004 and 2007, she also received the competitive Nishimura Scholarship while pursuing her doctoral degree in Japan. Earlier in her career, she was awarded the National Science and Technology Fellowship in Bangladesh during 1996-1997, which supported her postgraduate research. Additionally, Dr. Islam has secured multiple research grants from the University Grants Commission (UGC) of Bangladesh, including funding for significant projects related to genetic mutation analysis and the detection of foodborne pathogens. Her project on the mutation analysis of the HBB gene in beta-thalassemic patients and the detection of Staphylococcus aureus in frozen chicken rinse are examples of her impactful, grant-funded research. These honors and recognitions underline her dedication to advancing genetic and microbial research and affirm her position as a respected leader in the academic and scientific communities.

Conclusion

Prof. Dr. Nazneen Naher Islam is a distinguished researcher, educator, and leader whose contributions to microbial genetics, public health microbiology, and genetic disease studies have had significant impact both within Bangladesh and in the broader scientific community. Her multidisciplinary research integrates cutting-edge molecular biology techniques with practical applications in public health and the food industry. Throughout her career, she has demonstrated remarkable dedication to education by supervising a large number of graduate students and by delivering high-quality teaching in genetic engineering and biotechnology. Her professional affiliations, international collaborations, and consistent involvement in research grants and scholarly publishing reflect her commitment to academic excellence and community service. While further engagement in international conferences and collaborations could amplify her global presence, Dr. Islam’s track record clearly positions her as a leading researcher in her field. Her ability to address critical health issues through research, coupled with her passion for student mentorship and institutional leadership, make her a highly deserving candidate for prestigious recognitions such as the Best Researcher Award. Her continued work is expected to contribute substantially to the advancement of biotechnology, public health, and genetic research in Bangladesh and beyond.

Publications Top Notes

  1. Title: Antibacterial Activity of Terminalia Chebula and Erythrina Variegata Extracts against Pathogen Causing Respiratory Tract Infection
    Authors: Chandrika Das, Dil Umme Salma Chowdhury, Md. Abdul Mannan, Nazneen Naher Islam
    Year: 2021

  2. Title: Plasmid profiling of multiple antibiotic-resistant Pseudomonas aeruginosa isolated from soil of the industrial area in Chittagong, Bangladesh
    Authors: Asma Talukder, Md. Mijanur Rahman, Mohammed Mehadi Hassan Chowdhury, Tanha Amina Mobashshera, Nazneen Naher Islam
    Year: 2021

  3. Title: Assessment of molecular and clinical characteristics in blood transfusion dependent HbE/β-thalassemia patients
    Authors: Nazneen Naher Islam, Mohabbat Hossain, Shuvo Chandra Das, Sabrina Alam Seuti, Razia Sultana, Mahmood A. Chowdhury
    Year: 2020

  4. Title: Vibrio cholerae transmits through water among the household contacts of cholera patients in cholera endemic coastal villages of Bangladesh, 2015-2016 (CHoB17 Trial)
    Authors: Zillur Rahman, Md. Anisur Rahman, Mahamud-ur-Rashid, Shirajum Monira, Fatema-Tuz Johura, Munshi Mustafiz, Sazzadul I. Bhuyian, Fatema Zohura, Tahmina Parvin, Khaled Hasan, K. M. Saif-Ur-Rahman, Nazneen Naher Islam, David A. Sack, Christine M. George, Munirul Alam
    Year: 2018

  5. Title: Bacteriological and ecfX-gene specific PCR based identification of Pseudomonas aeruginosa isolated from Chittagong industrial area and characterization of its extracellular amylase
    Authors: Asma Talukder, Tanha Amina Mobashshera, Istiaq Uddin Ahmed, Nazneen Naher Islam
    Year: 2018

  6. Title: Identification and Screening of Lactobacillus spp. from Selective Regional Yoghurts for Probiotic and Interference with Pathogenic Bacterial Growth
    Authors: Kamrun Naher Islam, Touaha Akbar, Fahmida Akther, Nazneen Naher Islam
    Year: 2016

  7. Title: Detection of Staphylococcus aureus in Frozen Chicken Rinse through Bacteriological and Nuc Gene specific PCR Methods and Drug resistance Patterns in Southern Chittagong, Bangladesh
    Authors: Nazneen Naher Islam, Mahmuda Akter, Zinat Farzana, Abdul Jabber Bin Kader, Inkeyas Uddin, AMAM Zonaed Siddiki, K M Kamaruddin
    Year: 2014

Shane Scott | Molecular Biology | Best Researcher Award

Dr. Shane Scott | Molecular Biology | Best Researcher Award

Medical Student from The Ohio State College of Medicine, United States

Dr. Shane Shakar Scott is a distinguished physician-scientist whose career seamlessly integrates clinical medicine, biomedical research, and health equity advocacy. Currently enrolled in the Medical Scientist Training Program (MSTP) at The Ohio State University College of Medicine, he is pursuing both an MD and a PhD. His doctoral research focuses on the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure, contributing significantly to the field of cardio-oncology. Dr. Scott’s work has been published in reputable journals, including Heart Failure Clinics, where he co-authored a review on intracellular signaling pathways mediating tyrosine kinase inhibitor cardiotoxicity . Beyond his research, he has demonstrated leadership through roles such as National Delegate for Medical Education at the Association of American Medical Colleges (AAMC) and co-founder of the American Association of Black Physician Scientists. His commitment to mentorship and community service is evident in his involvement with various educational programs and initiatives aimed at increasing diversity in the medical field. Dr. Scott’s multifaceted contributions position him as a leading figure in advancing both scientific knowledge and social equity in healthcare.

Professional Profile

Education

Dr. Scott’s academic journey reflects a steadfast commitment to excellence and interdisciplinary scholarship. He earned his Bachelor of Science degrees in Biochemistry and Chemistry from Brandeis University, graduating with high honors. He then pursued a Master of Science in Medical Sciences at Boston University School of Medicine, where his research centered on the intracellular localization and effects of the TAAR1 receptor. Currently, Dr. Scott is enrolled in the Medical Scientist Training Program at The Ohio State University College of Medicine, undertaking both MD and PhD degrees. His doctoral dissertation, titled “Electrical and Structural Dysfunction Underlying Tyrosine Kinase Inhibitor Cardiotoxicity and βII-spectrin Deficient Heart Failure,” delves into the molecular mechanisms of cardiotoxicity associated with cancer therapies. This rigorous academic foundation equips Dr. Scott with a unique perspective that bridges basic science and clinical application, enhancing his capacity to contribute meaningfully to translational medicine.

Professional Experience

Dr. Scott’s professional experience encompasses a blend of research, teaching, and leadership roles. As a graduate trainee at the Davis Heart and Lung Research Institute, he investigated the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure. His earlier research at the National Institute of Mental Health focused on the intracellular effects of TAAR1 activation and the axonal trafficking of tyrosine hydroxylase mRNA. In addition to his research endeavors, Dr. Scott has contributed to medical education as a lecturer and course designer, developing curricula aimed at improving awareness and equitable treatment of Black-identified patients. His leadership roles include serving as President of the OSU College of Medicine Class of 2023 and co-founding the American Association of Black Physician Scientists. These experiences underscore his dedication to advancing both scientific inquiry and social justice within the medical community.

Research Interests

Dr. Scott’s research interests lie at the intersection of cardiology, oncology, and molecular biology. He is particularly focused on understanding the mechanisms underlying cardiotoxicity induced by cancer therapies, such as tyrosine kinase inhibitors. His work explores how these treatments affect cardiac signaling pathways and contribute to structural and functional heart abnormalities. Additionally, Dr. Scott investigates the role of βII-spectrin in cardiac dyad organization and its implications for heart failure. His research aims to identify potential therapeutic targets to mitigate adverse cardiac effects in cancer patients, thereby improving their overall treatment outcomes. Through his studies, Dr. Scott contributes to the emerging field of cardio-oncology, which seeks to balance effective cancer treatment with the preservation of cardiovascular health.

Research Skills

Dr. Scott possesses a comprehensive skill set that encompasses various aspects of biomedical research. His expertise includes molecular biology techniques such as qRT-PCR, in situ hybridization, and Western blotting, which he has applied to study gene expression and protein localization. He is proficient in electrophysiological methods, having investigated arrhythmogenic mechanisms in animal models. Dr. Scott has also utilized advanced imaging techniques to assess cardiac structure and function. His experience extends to the development of organelle-targeted FRET reporters for studying intracellular signaling pathways. Furthermore, he has demonstrated competence in designing and conducting translational research studies that bridge bench science and clinical application. These skills enable Dr. Scott to contribute effectively to multidisciplinary research teams and advance our understanding of complex biomedical phenomena.

Awards and Honors

Dr. Scott’s academic and professional achievements have been recognized through numerous awards and honors. He is a recipient of the Cummins Dyche Medical Scholarship and the Viola Cranston Erb Scholarship from The Ohio State College of Medicine. His research excellence earned him the Neff MSTP Travel Award and the DHLRI Graduate Student of the Year Award Finalist designation. Dr. Scott was inducted into the Golden Humanism Honor Society, reflecting his commitment to compassionate patient care. He received the Society of Thoracic Surgery’s Looking to the Future Scholarship and was featured by the Association of American Medical Colleges in an article highlighting his resilience and determination. These accolades underscore his dedication to advancing medical science and education while exemplifying the highest standards of professionalism and humanism.

Conclusion

Dr. Shane Shakar Scott exemplifies the qualities of an outstanding researcher and leader in the medical field. His interdisciplinary approach, combining rigorous scientific investigation with a commitment to social equity, positions him as a transformative figure in healthcare. Through his research on cardiotoxicity and heart failure, Dr. Scott contributes valuable insights that have the potential to improve patient outcomes. His dedication to mentorship, education, and community service reflects a holistic understanding of the physician-scientist’s role. As he continues to bridge the gap between bench research and clinical practice, Dr. Scott’s work will undoubtedly have a lasting impact on both scientific knowledge and the well-being of diverse patient populations.

Publications Top Notes

  1. Title: Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
    Journal: Heart Failure Clinics
    Year: 2022 (June)
    DOI: 10.1016/j.hfc.2022.02.003
    Author: Shane Shakar Scott

  2. Title: In Vivo to Ex Vivo High Resolution Optical Mapping and Contrast Enhanced Magnetic Resonance Imaging to Reveal Atrial Fibrillation Drivers and Improve Identification of Arrhythmogenic Structural Substrates in Persistent Atrial Fibrillation Canine Model
    Journal: Heart Rhythm
    Year: 2021 (August)
    DOI: 10.1016/j.hrthm.2021.06.937
    Author: Shane Shakar Scott

  3. Title: Comprehensive Evaluation of Electrophysiological and 3D Structural Features of Human Atrial Myocardium with Insights on Atrial Fibrillation Maintenance Mechanisms
    Journal: Journal of Molecular and Cellular Cardiology
    Year: 2021 (February)
    DOI: 10.1016/j.yjmcc.2020.10.012
    Author: Shane Shakar Scott

  4. Title: The Local Expression and Trafficking of Tyrosine Hydroxylase mRNA in the Axons of Sympathetic Neurons
    Journal: RNA
    Year: 2016 (April)
    DOI: 10.1261/rna.053272.115
    Authors: Noreen M. Gervasi; Shane S. Scott; Armaz Aschrafi; Jenna Gale; Sanah N. Vohra; Margaret A. MacGibeny; Amar N. Kar; Anthony E. Gioio; Barry B. Kaplan

Shengtai Bian | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. Shengtai Bian | Molecular Biology | Best Researcher Award

Association Professor from BEIJING SPORT UNIVERSITY, China

Dr. Shengtai Bian is a distinguished academic and researcher specializing in biomedical engineering, currently serving as an Associate Professor in the School of Sport Science at Beijing Sport University. He also leads the Microfluidics Research & Innovation Laboratory, where he spearheads innovative studies on wearable technologies and health-monitoring devices. With a strong background in microfluidic and electrochemical sensor development, Dr. Bian’s work bridges the domains of material science, biomedical engineering, and sports science. His research focuses on non-invasive monitoring using biofluids such as sweat, interstitial fluid (ISF), and saliva, addressing growing demands in preventive healthcare and point-of-care diagnostics. His research excellence stems from a solid academic foundation, forward-thinking approaches, and interdisciplinary integration. As a principal investigator, he contributes significantly to the academic and technological advancement of wearable sensor systems that can detect physiological signals in real-time. Dr. Bian’s leadership in innovation and scientific inquiry has earned him recognition among the academic and healthcare technology communities. His ability to translate fundamental research into applied solutions makes him a prominent figure in his field. He continues to advance new frontiers in health monitoring by integrating polymeric materials, flexible electronics, and biosensing technologies, setting a benchmark for modern biomedical applications.

Professional Profile

Education

Dr. Shengtai Bian earned his Doctor of Engineering degree in Biomedical Engineering from Tsinghua University, one of the most prestigious and competitive universities in China. Tsinghua University is globally recognized for its strong emphasis on science and technology, and Dr. Bian’s doctoral education provided him with rigorous training in the development and application of advanced biomedical technologies. His doctoral research cultivated a deep understanding of sensor systems, microfluidics, and materials science, laying the groundwork for his future contributions to wearable and point-of-care medical devices. The program also fostered his analytical thinking and research design skills, enabling him to work across disciplines with a strong problem-solving approach. His academic formation at Tsinghua placed him at the cutting edge of emerging biomedical technologies, encouraging innovation and translational research. In addition to core biomedical engineering competencies, Dr. Bian gained experience in collaborative, cross-functional research, particularly in working with interdisciplinary teams that included professionals from fields such as polymer chemistry, electrical engineering, and clinical medicine. This educational experience not only equipped him with in-depth theoretical knowledge but also inspired his current research trajectory focused on wearable microfluidic and electrochemical sensor development for health monitoring applications.

Professional Experience

Dr. Shengtai Bian is currently an Associate Professor in the School of Sport Science at Beijing Sport University, where he also serves as the Principal Investigator of the Microfluidics Research & Innovation Laboratory. In this role, he leads a multidisciplinary team focused on developing wearable health-monitoring devices using microfluidic and electrochemical sensing technologies. His academic appointment has allowed him to merge the fields of sport science, biomedical engineering, and material innovation, applying his expertise to real-world challenges in health and athletic performance monitoring. Dr. Bian’s professional journey has been characterized by progressive leadership and a commitment to impactful research. He is actively involved in teaching, mentoring graduate students, and supervising research projects that aim to develop practical diagnostic and monitoring tools. His work often bridges the academic and applied sectors, and he has established collaborations with both industry partners and academic institutions. Beyond his responsibilities in academia, Dr. Bian frequently participates in research forums and contributes to scientific publications. His professional experience has positioned him as a thought leader in wearable biosensing and applied biomedical technologies. His contributions not only elevate the academic standing of his institution but also play a vital role in shaping the next generation of medical monitoring systems.

Research Interest

Dr. Shengtai Bian’s research interests lie at the intersection of biomedical engineering, wearable technology, and health diagnostics. He is particularly focused on the development of microfluidic and electrochemical sensors for the non-invasive detection of biomarkers in biofluids such as sweat, interstitial fluid (ISF), and saliva. This approach enables real-time health monitoring, making it highly relevant for both clinical and athletic performance applications. His work emphasizes the use of flexible and biocompatible materials to create user-friendly, skin-adherent sensors that can operate continuously and wirelessly. He is also deeply engaged in advancing Point-of-Care Testing (POCT) systems that provide immediate diagnostic information outside traditional laboratory settings, supporting the growing demand for decentralized healthcare. Another core area of his interest is high polymer materials, which serve as foundational elements in the construction of durable, flexible, and sensitive biosensors. By integrating materials science, nanotechnology, and electrochemistry, Dr. Bian aims to develop holistic platforms for personalized health management. His interdisciplinary focus is aligned with global trends in preventive healthcare and digital health solutions. Ultimately, Dr. Bian’s research strives to provide innovative tools that are accessible, affordable, and capable of improving quality of life through early detection and continuous monitoring of physiological conditions.

Research Skills

Dr. Shengtai Bian possesses an extensive array of research skills that contribute to his excellence in the field of biomedical sensing technologies. He is highly skilled in microfluidic device fabrication, including soft lithography, 3D printing, and polymer casting techniques, which are essential for creating small-scale, efficient, and integrable systems for biofluid analysis. His proficiency in electrochemical sensor design enables him to construct precise, sensitive, and stable biosensing platforms for a wide range of health monitoring applications. Dr. Bian has deep expertise in the selection and manipulation of high-performance polymeric materials, which he integrates into flexible and wearable electronics for human health diagnostics. His analytical capabilities include signal processing, biofluid composition analysis, and the calibration of sensors for accurate real-time feedback. Moreover, Dr. Bian is experienced in working with interdisciplinary teams, which enhances his ability to apply his technical skills to real-world healthcare scenarios. He is adept at combining experimental and theoretical methods to validate his devices and systems. His skill set also includes project management, academic writing, grant proposal development, and mentoring, all of which reinforce his leadership in research environments. Collectively, his technical and managerial skills make him a versatile and effective innovator in biomedical engineering.

Awards and Honors

While specific awards and honors for Dr. Shengtai Bian are not explicitly mentioned, his professional standing and leadership roles suggest a commendable track record of academic recognition. As an Associate Professor and Principal Investigator of a dedicated research laboratory, he has achieved a level of distinction typically earned through sustained contributions to science and technology. His selection to lead the Microfluidics Research & Innovation Laboratory indicates institutional trust in his vision and capabilities. Such positions are often awarded based on demonstrated research productivity, innovation, and mentorship. It is reasonable to assume that he has been the recipient of internal grants, competitive research funding, or recognition within his university or research networks for his work in biomedical sensors and wearable technology. Participation in peer-reviewed publications, invited talks, and academic conferences also reflects recognition by the broader scientific community. As his career continues to evolve, further documentation of his awards, patents, and high-impact publications would solidify his profile as a leading figure in this domain. Regardless, his current role and research leadership are testaments to his academic merit and the impact of his work in advancing next-generation health monitoring technologies.

Conclusion

Dr. Shengtai Bian stands out as a forward-thinking researcher whose work aligns with global healthcare trends emphasizing non-invasive, real-time health monitoring. His expertise in microfluidic and electrochemical sensors, coupled with his commitment to interdisciplinary research, places him at the forefront of innovation in wearable health technologies. As an Associate Professor and Principal Investigator, he has demonstrated strong leadership, academic rigor, and a dedication to translating research into practical applications. While additional documentation of his awards, publications, and collaborative engagements would further bolster his candidacy, his ongoing contributions to biomedical engineering already reflect a high level of excellence. His ability to integrate materials science, biosensing, and wearable technology into health solutions makes his research both timely and impactful. He addresses critical challenges in personalized healthcare and preventive diagnostics, which are key priorities in modern medicine and sports science. In conclusion, Dr. Bian is a strong contender for any recognition honoring research excellence, particularly in the domain of biomedical engineering and wearable diagnostics. His vision, research focus, and leadership qualities make him a valuable contributor to the scientific community and a deserving candidate for prestigious research awards.

Publications Top Notes

  1. Antibacterial hydrogel: The sniper of chronic wounds
    Authors: Shengtai Bian, Huijun Ye, Pan Wang, Ming Guan, Shilun Feng
    Year: Not specified
    Citations: 1

Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assistant Professor at Al-Tibri Medical College, Pakistan

Dr. Mehwish Zehravi is an accomplished academic and researcher specializing in pathology with a focus on stem cell culture, genetic analysis, and regenerative medicine. Currently serving as an Assistant Professor in the Department of Pathology at Al-Tibri Medical College, Karachi, she has contributed significantly to teaching, research, and clinical practices. Her expertise spans advanced laboratory techniques, including human stem cell culture, whole exome sequencing, and immunofluorescence microscopy. With a strong academic foundation, Dr. Zehravi has published in reputed journals and presented her research at notable platforms. Her work on identifying genetic mutations in muscular dystrophy patients has been recognized internationally, with findings published in the Leiden Open Variant Database. A dedicated professional, she continuously enhances her skills through workshops, certifications, and collaborative research.

Professional Profile

Education

Dr. Zehravi holds an M.Phil. in Pathology from Dow University of Health Sciences, Karachi, with a commendable CGPA of 3.48, achieved in 2020. She earned her M.B.B.S. from the same institution in 2012, securing a CGPA of 3.06. Her academic journey also includes pre-medical studies at B.A.M.M. P.E.C.H.S. Govt. College for Women, Karachi, and matriculation at St. Patrick’s Girls High School, Karachi, where she excelled with distinction. She has actively pursued professional development through various certifications, including the Certificate of Health Professional Education from Liaquat National Hospital and workshops on bioinformatics, sample size calculation, and learning management systems.

Professional Experience

Dr. Zehravi has a diverse professional background combining academic, clinical, and research expertise. Currently, she serves as an Assistant Professor at Al-Tibri Medical College, where she previously worked as a Senior Lecturer. Her teaching career is complemented by hands-on experience in various clinical settings, including roles as a Resident Medical Officer at Sambro’s Hospital, Sindh Institute of Urology and Transplantation, and Civil Hospital, Karachi. She has also contributed to the field as a researcher at the Stem Cells & Regenerative Medicine Lab at Dow University, focusing on advanced genetic studies and stem cell culture techniques. Her extensive house job experience across surgery, gynecology, pediatrics, and medicine further solidifies her clinical expertise.

Research Interests

Dr. Zehravi’s research focuses on regenerative medicine, stem cell culture, and genetic disorders. She is particularly interested in understanding the mutational profiles of diseases like muscular dystrophy and leveraging induced pluripotent stem cells for therapeutic purposes. Her work also delves into molecular and cellular biology techniques, such as transfection, PCR, flow cytometry, and sequencing technologies. She is passionate about exploring new avenues in bioinformatics and integrating advanced laboratory techniques to address complex medical challenges. Dr. Zehravi’s contributions to genetic research aim to enhance understanding and treatment options for inherited diseases, aligning her work with global scientific advancements.

Research Skills

Dr. Zehravi possesses a robust set of research skills, including expertise in human stem cell culture, transfection using episomal plasmids, and advanced genetic sequencing techniques like Sanger and whole exome sequencing. She is proficient in DNA extraction, gel electrophoresis, PCR, and flow cytometry. Her technical expertise extends to phase contrast and immunofluorescence microscopy, alongside reprogramming techniques using Neon Transfection Systems. Additionally, she is adept at statistical analysis using SPSS and reference management tools like EndNote. These skills have enabled her to make significant contributions to understanding genetic mutations and developing innovative therapeutic approaches.

Awards and Honors

Dr. Zehravi has earned recognition for her impactful research and professional accomplishments. Her study on genetic mutations in muscular dystrophy patients was the first from Pakistan to be included in the Leiden Open Variant Database, marking a milestone in global genetic research. She has also presented her research findings at prestigious conferences, such as her survey on euthanasia perspectives at Dow University. Furthermore, she has consistently demonstrated academic excellence, earning top grades throughout her educational journey. Her commitment to professional development is evident through her participation in numerous workshops, training sessions, and certifications.

Conclusion

Dr. Mehwish Zehravi is a dedicated researcher and academic whose work bridges the gap between education, clinical practice, and cutting-edge research. With a strong foundation in pathology, she has significantly contributed to the study of genetic disorders and regenerative medicine. Her innovative research, particularly in muscular dystrophy, has gained international recognition. Alongside her academic and research pursuits, Dr. Zehravi actively participates in workshops and certifications to stay updated with advancements in her field. With her exceptional skills and passion for medical research, Dr. Zehravi is a worthy candidate for the Best Researcher Award, embodying excellence, innovation, and dedication to improving healthcare outcomes.

Publication Top Notes

  1. Whole-Exome Sequencing Identifies Small Mutations in Pakistani Muscular Dystrophy Patients
    • Authors: Zehravi, M., Wahid, M., Ashraf, J., Fatima, T.
    • Year: 2021
    • Citations: 1
  2. Episomal Reprogramming of Duchenne Muscular Dystrophy Patients Derived CD3+ T Cells Towards Induced Pluripotent Stem Cells
    • Authors: Zehravi, M., Wahid, M., Ashraf, J.
    • Year: 2021
    • Citations: 1

 

Mario D. Cordero | Molecular Biology | Best Researcher Award

Dr. Mario D. Cordero | Molecular Biology | Best Researcher Award

Principal Investigator at Pablo de Olavide University, Spain

Mario David Cordero Morales is a distinguished professional and researcher known for his contributions to [specific field/area of expertise]. With a robust academic foundation and a wealth of experience in both academia and industry, he has demonstrated an unwavering commitment to advancing knowledge and fostering innovation. His career is marked by interdisciplinary collaboration, a keen focus on applied research, and significant contributions to [specific applications or innovations]. A recipient of numerous accolades, Mario David is recognized as a leader who consistently bridges the gap between theoretical research and practical implementation.

Professional Profile

Education

Mario David Cordero Morales holds an extensive academic background that has laid the groundwork for his professional success. He earned his [degree] in [field] from [university], where he developed expertise in [key area]. Building on this, he pursued advanced studies, completing a [degree/doctorate] in [specific specialization] at [university], with a thesis focusing on [specific topic]. His educational journey also includes specialized training and certifications in [specific courses], ensuring his alignment with emerging trends and technologies.

Professional Experience

With [X years] of professional experience, Mario David has held pivotal roles in academia, research, and industry. As [current position] at [organization], he leads initiatives in [key responsibilities]. Previously, he contributed significantly as [previous roles] at [institutions/organizations], where he worked on groundbreaking projects like [specific projects]. His professional journey reflects a trajectory of increasing responsibility and influence, with a focus on [core professional themes].

Research Interests

Mario David’s research interests lie at the intersection of [fields], particularly focusing on [specific topics]. His work seeks to address critical challenges in [industry/area], leveraging [specific methodologies or technologies]. He has a strong passion for exploring [emerging topics], which has positioned him as a thought leader in [field]. Through collaboration with global researchers, Mario continues to pioneer advancements in [specific innovations].

Research Skills

Mario David is equipped with a diverse set of research skills that enhance his contributions to [field]. Proficient in [specific methodologies], he excels in [technical skills like data analysis, modeling, lab techniques]. His expertise in [tools/software] enables him to tackle complex research problems efficiently. He is adept at designing and managing large-scale projects, fostering interdisciplinary collaboration, and mentoring junior researchers to achieve excellence.

Awards and Honors

Mario David has received numerous accolades recognizing his excellence in research and professional contributions. Notable honors include [specific awards], which highlight his impact on [field]. He has also been awarded fellowships and grants from esteemed organizations like [specific institutions]. His dedication to [specific cause or innovation] has earned him accolades that underscore his status as a respected figure in [industry/field].

Conclusion

Mario David Cordero Morales is an exemplary researcher with a compelling journey and significant contributions to biomedical research. His work on inflammasomes and aging is both innovative and impactful, supported by an impressive publication record, international collaborations, and leadership in advancing knowledge in this field. While there is scope for diversification and industry engagement, his achievements, resilience, and scientific influence make him a strong contender for the Best Researcher Award.

Publication Top Notes

1.The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Boy-Ruiz, D., Sanz, A., Cordero, M.D.
  • Year: 2024
  • Journal: Aging Cell
  • Volume and Issue: 23(9), e14272

2. Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?

  • Authors: Suarez-Rivero, J.M., López-Pérez, J., Astorga-Gamaza, A., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 41(7-9), pp. 479–487

3. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Gallardo-Orihuela, A., Mbalaviele, G., Cordero, M.D.
  • Year: 2024
  • Journal: Inflammation Research
  • Volume and Issue: 73(8), pp. 1253–1266
  • Citations: 2

4. Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?

  • Authors: López-Pérez, J., Suarez-Rivero, J.M., Muela-Zarzuela, I., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 40(13-15), pp. 751–758
  • Citations: 1

5. Modulatory effect of Andean blackberry polyphenols on genes related to antioxidant and inflammatory responses, the NLRP3 inflammasome, and autophagy

  • Authors: Castejón-Vega, B., Kyriakidis, N.C., Alcócer-Gómez, E., Cordero, M.D., Alvarez-Suarez, J.M.
  • Year: 2024
  • Journal: Journal of Berry Research
  • Volume and Issue: 14(1), pp. 41–59
  • Citations: 1

6. How the Disruption of Mitochondrial Redox Signalling Contributes to Ageing

  • Authors: Castejon-Vega, B., Cordero, M.D., Sanz, A.
  • Year: 2023
  • Journal: Antioxidants
  • Volume and Issue: 12(4), 831
  • Citations: 8

7. L-arginine ameliorates defective autophagy in GM2 gangliosidoses by mTOR modulation

  • Authors: Castejón-Vega, B., Rubio, A., Pérez-Pulido, A.J., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: Cells
  • Volume and Issue: 10(11), 3122
  • Citations: 3

8. Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria

  • Authors: González-Dominguez, A., Montañez, R., Castejón-Vega, B., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: EMBO Molecular Medicine
  • Volume and Issue: 13(10), e14012
  • Citations: 19

9. Glial cells (Book Chapter)

  • Authors: Williams, M., Macdonald, C., Cordero, M.D.
  • Year: 2021
  • Book: The Neuropathology of Schizophrenia
  • Pages: 221–241

10. Potential role of the mitochondria for the dermatological treatment of Papillon-Lefèvre

  • Authors: Castejón-Vega, B., Battino, M., Quiles, J.L., Cordero, M.D., Bullón, P.
  • Year: 2021
  • Journal: Antioxidants
  • Volume and Issue: 10(1), pp. 1–9, 95
  • Citations: 5

 

 

 

Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Dr. Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Additional Professor at All India Institute Of Medical Sciences Bhopal, India

Dr. Sukhes Mukherjee is a distinguished academic and researcher in the field of biochemistry, with a focus on clinical biochemistry and molecular biology. He currently holds the position of Additional Professor at the All India Institute of Medical Sciences (AIIMS), Bhopal, India. Dr. Mukherjee has built an impressive career over the past 16 years, with substantial contributions to research and education. His work has been widely recognized, earning him numerous awards and honors. He is also known for his leadership in teaching and mentoring students, particularly at the postgraduate level. Dr. Mukherjee’s research focuses on advancing molecular techniques in biochemistry, with an emphasis on health diagnostics and disease management. He has authored over 80 peer-reviewed papers and frequently contributes to conferences and seminars both nationally and internationally.

Professional Profile

Education

Dr. Mukherjee’s educational journey is anchored in biochemistry and molecular biology. He completed his undergraduate and postgraduate education in India, earning a Master’s degree in Medical Biochemistry, followed by a Ph.D. in Biochemistry. His academic training has provided him with a strong foundation in both theoretical knowledge and hands-on laboratory skills. Dr. Mukherjee’s education is complemented by postdoctoral research experiences that have enriched his expertise in clinical biochemistry and molecular diagnostics. He has actively engaged in interdisciplinary training programs and research initiatives, which have shaped his current position as a thought leader in the field.

Professional Experience

Dr. Mukherjee’s professional experience spans more than 16 years, during which he has worked at various prestigious institutions, most notably at AIIMS, Bhopal. In his current role, he is responsible for overseeing clinical biochemistry research, teaching, and administration. Dr. Mukherjee has taught a wide range of courses, from basic biochemistry to advanced molecular biology, guiding both undergraduate and postgraduate students. Additionally, he has served on various academic and research committees, contributing to the development of new curricula and research protocols. His career also includes serving as a mentor to numerous graduate students and postdoctoral researchers, helping them advance their scientific careers.

Research Interests

Dr. Mukherjee’s primary research interests lie in the fields of clinical biochemistry, molecular biology, and health diagnostics. His work focuses on understanding the molecular mechanisms of disease, with particular attention to neurochemistry and biochemical pathways in neurological disorders. He is involved in exploring novel diagnostic biomarkers and therapies to improve patient care. Dr. Mukherjee’s research also covers the application of cutting-edge molecular biology techniques to better understand human health and disease at the cellular and biochemical levels. His interdisciplinary approach includes collaborations with clinicians and other researchers to bridge the gap between benchside research and clinical applications.

Research Skills

Dr. Mukherjee is highly skilled in a range of laboratory techniques and methodologies that are integral to biochemistry and molecular biology. These include protein chemistry, molecular cloning, enzyme assays, and biochemical profiling. He is proficient in various advanced diagnostic techniques, such as mass spectrometry and PCR-based methods, that are essential in clinical research. Dr. Mukherjee also has extensive experience in bioinformatics and data analysis, utilizing computational tools to interpret complex biological data. His research skills are complemented by his ability to manage large-scale research projects and collaborate effectively with multidisciplinary teams.

Awards and Honors

Dr. Mukherjee’s contributions to biochemistry and molecular biology have been recognized through numerous awards and honors. Notably, he received the Best Paper Award from the Association of Clinical Biochemists of India in 2008. He has been a recipient of various travel fellowships to attend and present at international conferences, including those in the US and South Korea. Dr. Mukherjee is a Fellow of the Linnean Society of London, reflecting his international stature in the scientific community. His work continues to attract recognition, both in India and globally, for its impact on advancing clinical biochemistry and molecular diagnostics.

Conclusion

Dr. Sukhes Mukherjee is undoubtedly a highly deserving candidate for the Best Researcher Award, with an impressive record of research contributions, academic excellence, and professional recognition. His extensive research, leadership, and dedication to advancing the field of clinical biochemistry set him apart as a pioneer in his field. With a bit more focus on interdisciplinary research and mentorship, Dr. Mukherjee could have an even more profound influence on both the scientific community and society at large. This nomination reflects his exemplary contributions and positions him as a role model for future researchers in the field.

Publication Top Notes

  1. Alcoholism and its effects on the central nervous system
    Authors: S Mukherjee
    Journal: Current Neurovascular Research 10 (3), 256-262
    Year: 2013
    Citations: 138
  2. Consequences of alcohol consumption on neurotransmitters-an overview
    Authors: S Mukherjee, SK Das, K Vaidyanathan, DM Vasudevan
    Journal: Current Neurovascular Research 5 (4), 266-272
    Year: 2008
    Citations: 86
  3. Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease
    Authors: SK Das, V Balakrishnan, S Mukherjee, DM Vasudevan
    Journal: Scandinavian Journal of Clinical and Laboratory Investigation 68 (4), 323-334
    Year: 2008
    Citations: 81
  4. Oxidative stress is the primary event: effects of ethanol consumption in brain
    Authors: SK Das, KR Hiran, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 22, 99-104
    Year: 2007
    Citations: 77
  5. Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver
    Authors: SK Das, S Mukherjee, DM Vasudevan, V Balakrishnan
    Journal: Singapore Med J 52 (3), 175-181
    Year: 2011
    Citations: 73
  6. Medicinal properties of milk thistle with special reference to silymarin–an overview
    Authors: SK Das, S Mukherjee, DM Vasudevan
    Publisher: CSIR
    Year: 2008
    Citations: 70
  7. Evolving interplay between dietary polyphenols and gut microbiota—an emerging importance in healthcare
    Authors: SK Ray, S Mukherjee
    Journal: Frontiers in Nutrition 8, 634944
    Year: 2021
    Citations: 68
  8. Biochemical and immunological basis of silymarin effect, a milk thistle (Silybum marianum) against ethanol-induced oxidative damage
    Authors: SK Das, S Mukherjee
    Journal: Toxicology Mechanisms and Methods 22 (5), 409-413
    Year: 2012
    Citations: 63
  9. Protective effect of resveratrol and vitamin E against ethanol-induced oxidative damage in mice: biochemical and immunological basis
    Authors: SK Das, S Mukherjee, G Gupta, DN Rao, DM Vasudevan
    Publisher: CSIR
    Year: 2010
    Citations: 55
  10. Effects of chronic ethanol exposure on renal function tests and oxidative stress in kidney
    Authors: SK Das, S Varadhan, L Dhanya, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 23, 341-344
    Year: 2008
    Citations: 49

 

Rui Wen | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Rui Wen | Molecular Biology | Best Researcher Award

Assistant Professor Dr at Wenzhou Medical University, China

Rui Wen, an Assistant Professor at Wenzhou Medical University in China, has focused on advancing research in biomaterials, with a special interest in silk proteins for drug delivery systems. Since earning his PhD in Biomaterials from Donghua University in 2020, Rui has quickly established a reputable profile through his publications in high-impact journals and his role in editorial positions. His work encompasses essential biological processes like protein function, alternative splicing, and gene expression, with an emphasis on the use of silk-based materials for medical applications. Rui is actively involved in peer-reviewed publications, authoring eight first-author or corresponding-author articles in prominent journals over the past five years. Additionally, he has contributed to the scientific community by serving as an editorial board member and reviewer for multiple journals, illustrating his influence and expertise in the field of biomaterials.

Professional Profile

Education

Rui Wen completed his PhD in Biomaterials at Donghua University in 2020, where he focused on the biological functions of protein materials, especially silk-based biomaterials for drug delivery. His doctoral research established foundational insights into protein functionality and biomimetic applications, shaping his future focus on protein function and genetic analysis. Throughout his education, Rui developed a sophisticated understanding of biomaterials science, from molecular genetics to applications in medical technology. His PhD laid a robust academic and technical foundation, equipping him with the essential research methodologies and laboratory skills needed to contribute meaningfully to the biomaterials field. The strong academic training he received at Donghua University, combined with hands-on experience in research, has been instrumental in his transition to his current role as an Assistant Professor, where he continues to leverage his expertise in gene expression and protein function.

Professional Experience

Rui Wen’s professional journey as an Assistant Professor at Wenzhou Medical University began shortly after he completed his PhD. In this role, Rui has focused his research on developing silk-based biomaterials for medical applications, such as drug delivery. His work often involves collaborations with other experts in the biomaterials and genetic research fields, emphasizing protein functionality and biomimetic design. Rui’s academic contributions include publishing eight peer-reviewed papers as the first or corresponding author in recognized journals, including Acta Biomaterialia and the International Journal of Biological Macromolecules. These achievements highlight his commitment to advancing scientific knowledge in biomaterials. Additionally, Rui serves on editorial boards for journals like the World Journal of Biological Chemistry, further underscoring his dedication to scientific excellence and community engagement. His involvement in these roles signifies his professional growth and increasing impact within the scientific community.

Research Interests

Rui Wen’s research interests are centered on protein function, gene expression, and biomaterials, particularly focusing on the medical potential of silk-based proteins. He is intrigued by the genetic underpinnings of protein function and the application of alternative splicing in creating materials that mimic biological functions. His work has a dual focus: understanding protein behavior at a genetic level and leveraging this knowledge to develop innovative biomaterials for drug delivery. This focus on silk-based proteins, a biologically compatible and robust material, has led Rui to explore how protein sequences can be harnessed to design highly specialized biomaterials with practical medical applications. Rui’s research aims to integrate genetic insights with material science to produce versatile, biocompatible materials that can advance drug delivery and other medical therapies, contributing to new solutions in biotechnology and healthcare.

Research Skills

Rui Wen possesses extensive research skills in biomaterials science and protein analysis. His expertise includes characterizing protein functionality, analyzing gene sequences, and applying genetic engineering principles to create innovative materials. Rui has a strong background in protein biochemistry and molecular biology, which has enabled him to identify and engineer silk proteins for biomimetic applications. Additionally, he is skilled in alternative splicing and concerted evolution, both of which play a crucial role in his work with gene expression. Rui’s laboratory skills include various analytical techniques, such as protein characterization assays, molecular modeling, and genetic sequencing. His ability to publish consistently in peer-reviewed journals reflects his proficiency in scientific communication and data analysis. Furthermore, his role as a reviewer and editor highlights his critical assessment skills, making him a valuable contributor to the scientific community.

Awards and Honors

Rui Wen’s contributions to biomaterials science have been recognized through multiple awards and honors. He received funding from the China Postdoctoral Science Foundation, a competitive grant that supports emerging researchers in China. This funding enabled him to continue his exploration of silk-based proteins and their applications in drug delivery. His role on the editorial boards of respected journals like the World Journal of Biological Chemistry and Biomedical Engineering Communications is another notable achievement, reflecting the respect he has earned among his peers. In addition, his status as an invited reviewer for journals such as the International Journal of Biological Macromolecules demonstrates his expertise and the high regard of the scientific community. These honors underscore Rui’s dedication to advancing biomaterials science and highlight his influence in the fields of protein function and gene expression.

Conclusion

Rui Wen is a dedicated and promising researcher whose accomplishments in the specialized areas of protein function and biomaterials are commendable for someone early in their career. His expertise, consistent publication record, and increasing engagement with the scientific community through editorial and reviewing activities make him a competitive candidate for the Best Researcher Award. With further developments in his citation impact and expanded international collaborations, Rui Wen’s contributions are likely to gain even greater visibility and influence, establishing him as a key figure in biomaterials research.

Publications Top Notes

  1. Title: Physical Properties of the Second Type of Aciniform Spidroin (AcSp2) from Neoscona theisi Reveal a pH-Dependent Self-Assembly Repetitive Domain
    Authors: Yang, D., Wang, S., Wang, K., Zan, X., Wen, R.
    Journal: ACS Biomaterials Science and Engineering
    Year: 2023
    Volume(Issue): 9(12)
    Pages: 6670–6682
    Citations: 1
  2. Title: Complete Gene Sequence and Mechanical Property of the Fourth Type of Major Ampullate Silk Protein
    Authors: Wen, R., Wang, S., Wang, K., Zan, X., Meng, Q.
    Journal: Acta Biomaterialia
    Year: 2023
    Volume: 155
    Pages: 282–291
    Citations: 4
  3. Title: Characterization of Two Full-Length Tubuliform Silk Gene Sequences from Neoscona theisi Reveals Intragenic Concerted Evolution and Multiple Copies in Genome
    Authors: Wen, R., Wang, K., Zan, X.
    Journal: International Journal of Biological Macromolecules
    Year: 2022
    Volume: 223
    Pages: 1015–1023
    Citations: 3
  4. Title: Characterization of Two Full-Length Araneus ventricosus Major Ampullate Silk Protein Genes
    Authors: Wen, R., Yang, D., Wang, K., Zan, X.
    Journal: International Journal of Biological Macromolecules
    Year: 2022
    Volume: 213
    Pages: 297–304
  5. Title: The Novel Aciniform Silk Protein (AcSp2-v2) Reveals the Unique Repetitive Domain with High Acid and Thermal Stability and Self-Assembly Capability
    Authors: Wen, R., Wang, K., Yang, D., Zan, X., Meng, Q.
    Journal: International Journal of Biological Macromolecules
    Year: 2022
    Volume: 202
    Pages: 91–101
    Citations: 6
  6. Title: Customized Flagelliform Spidroins Form Spider Silk-Like Fibers at pH 8.0 with Outstanding Tensile Strength
    Authors: Li, X., Qi, X., Cai, Y.-M., Meng, Q., Chen, G.
    Journal: ACS Biomaterials Science and Engineering
    Year: 2022
    Volume(Issue): 8(1)
    Pages: 119–127
    Citations: 14
  7. Title: Characterization of the Second Type of Aciniform Spidroin (AcSp2) Provides New Insight into Design for Spidroin-Based Biomaterials
    Authors: Wen, R., Wang, K., Meng, Q.
    Journal: Acta Biomaterialia
    Year: 2020
    Volume: 115
    Pages: 210–219
    Citations: 16
  8. Title: Two Novel Tubuliform Silk Gene Sequences from Araneus ventricosus Provide Evidence for Multiple Loci in Genome
    Authors: Wen, R., Wang, K., Meng, Q.
    Journal: International Journal of Biological Macromolecules
    Year: 2020
    Volume: 160
    Pages: 806–813
    Citations: 10
  9. Title: Wet-Spinning Synthetic Fibers from Aggregate Glue: Aggregate Spidroin 1 (AgSp1)
    Authors: Li, X., Mi, J., Wen, R., Meng, Q., Lin, Y.
    Journal: ACS Applied Bio Materials
    Year: 2020
    Volume(Issue): 3(9)
    Pages: 5957–5965
    Citations: 10
  10. Title: Novel Highly Soluble Chimeric Recombinant Spidroins with High Yield
    Authors: Jia, Q., Wen, R., Meng, Q.
    Journal: International Journal of Molecular Sciences
    Year: 2020
    Volume(Issue): 21(18)
    Pages: 1–13, Article ID: 6905
    Citations: 11

Francisca Louenny Alves Cardoso | Molecular Biology | Best Researcher Award

Ms. Francisca Louenny Alves Cardoso | Molecular Biology | Best Researcher Award

PhD student, Federal University of Piauí , Brazil

Francisca Louenny Alves Cardoso is a promising researcher currently pursuing a Ph.D. in Applied Technologies for Regional Animal Interests at Universidade Federal do Piauí, Brazil. With a Master’s degree in the same field, she specializes in mesenchymal stem cells, osteogenesis, and biomaterials. Francisca has contributed significantly to her area through multiple publications in scientific journals, exploring topics such as cytotoxicity and biomaterial development. She has received recognition for her work, including an honorable mention at an international congress. Her professional experience includes roles in various health laboratories and participation in impactful research projects, notably in epidemiological profiles of visceral leishmaniasis. Additionally, she actively engages in continuous education and has a specialization in Hematology and Hemotherapy. With strong communication skills in Portuguese and reasonable proficiency in English and Spanish, Francisca is well-prepared for collaborative research in biotechnology and biomedical engineering.

Profile:

Education

Francisca Louenny Alves Cardoso is currently pursuing a Ph.D. in Applied Technologies for Animals of Regional Interest at the Federal University of Piauí (UFPI), Brazil, with a focus on mesenchymal stem cells and biomaterials. She completed her Master’s degree in the same field at UFPI in 2023, where she explored the toxicity and osteogenesis related to laponite and scaffolds. Additionally, she holds a specialization in Hematology and Hemotherapy from União das Américas and a Bachelor’s degree in Biomedicine from Faculdade Maurício de Nassau, completed in 2019. Throughout her education, she has engaged in various scientific and professional development courses, including entrepreneurship and advanced reading in English, enhancing her expertise in biotechnology and biomedical engineering. Her academic background is further complemented by participation in international scientific jornadas, reflecting her commitment to ongoing learning and research in her field.

Professional Experience

Francisca Louenny Alves Cardoso has gained valuable professional experience in the field of biotechnology through various roles. In 2019, she served as an intern at both the Lablife Laboratory and the Central Public Health Laboratory of Piauí, where she contributed to research and laboratory operations. From 2021 to 2023, she worked at UNIFACID, initially under employment laws and later participating in project activities. Her research projects include epidemiological profiles of visceral leishmaniasis in Brazil and clinical assessments related to reduced seminal quality in men. Throughout her academic journey, Francisca has also engaged in teaching roles, providing her with a comprehensive understanding of both practical and theoretical aspects of biotechnology. Her diverse experiences have equipped her with a strong foundation in biological sciences, making her a promising candidate for further contributions to the field.

Research Skills

Francisca Louenny Alves Cardoso possesses a robust skill set in biotechnology, particularly in the fields of stem cell research, biomaterials, and medical engineering. Her research focuses on mesenchymal stem cells, osteogenesis, and the development of biocompatible scaffolds, showcasing her expertise in experimental applications involving regional animal species. With a strong foundation in both theoretical and practical aspects of biological sciences, she has actively contributed to several research projects, including studies on the cytotoxicity and genotoxicity of various materials. Cardoso’s proficiency in English, Spanish, and Portuguese enhances her ability to collaborate internationally, while her presentations at conferences and publications in scientific journals reflect her commitment to advancing knowledge in her field. Additionally, her ongoing Ph.D. work at the Universidade Federal do Piauí underscores her dedication to innovative research in biotechnology and biomedical engineering, positioning her as a valuable contributor to scientific advancements.

Award and Recognition

Francisca Louenny Alves Cardoso has made significant strides in the field of biotechnology, particularly in her research on mesenchymal stem cells and biomaterials. Her dedication to scientific excellence was recognized in 2019 when she received an honorable mention for her presentation on “Células Progenitoras Renais de Suínos” at the International Congress of Health Students and Professionals. This accolade highlights her ability to contribute valuable insights to her field. Additionally, her active participation in various scientific congresses and her authorship of multiple peer-reviewed articles further demonstrate her commitment to advancing knowledge in biological sciences. As she progresses through her Ph.D. studies, her ongoing contributions continue to establish her as a promising researcher within her specialization. Her achievements reflect not only her personal dedication but also her potential to impact the biotechnology landscape significantly. 🌟🔬

Conclusion

Francisca Louenny Alves Cardoso exemplifies the qualities of a strong candidate for the Best Researcher Award. Her robust educational background, impactful research contributions, and recognition in the scientific community position her as a promising researcher in the field of biotechnology. By focusing on expanding her networking opportunities and enhancing her grant-writing skills, she could further elevate her research career and contribute significantly to her field.

Publication Top Notes

  1. Title: Aspectos epidemiológicos associados à ocorrência de casos de esquistossomose no Brasil nos anos de 2007 a 2017
    Authors: André Cardoso Tavares; Francisca Louenny Alves Cardoso; Vitória Silva de Aragão; Tayana Vívian Ribeiro Bastos; Helder Matheus Alves Fernandes; Elane da Silva Barbosa; Éllen Nayane Beserra Torres; Amália Gonçalves Arruda; Márcia Jaínne Campelo Chaves; Maria Lucilane da Silva Sales
    Year: 2024
    Type: Book chapter
    DOI: 10.36926/editorainovar-978-65-5388-2133_004
    ISBN: 9786553882133
  2. Title: Cytotoxicity and genotoxic impacts of LAPONITE® on murine adipose stem cells
    Authors: Francisca L.A. Cardoso; Letícya L.S. Soares; Danielle B.A. Silva; Napoleão M. Argôlo Neto; Edson C. Silva Filho; Adalberto S. Silva; Dayseanny O. Bezerra; Maria S.P. Cruz; Felipe C. Nunes; Wanderson G.G. Melo et al.
    Year: 2024
    Journal: Applied Clay Science
    DOI: 10.1016/j.clay.2024.107572
    ISSN: 0169-1317
  3. Title: Development of a new biomaterial based on cashew tree gum (Anarcadium occidentale L.) enriched with hydroxyapatite and evaluation of cytotoxicity in adipose-derived stem cell cultures
    Authors: Lorenna Bastos Nogueira da Rocha; Ricardo Barbosa Sousa; Marcus Vinicius Beserra dos Santos; Napoleão Martins Argolo Neto; Letícya Lorrayne da Silva Soares; Francisca Louenny Cardoso Alves; Maria Acelina Martins de Carvalho; Josy Anteveli Osajima; Edson C. Silva-Filho
    Year: 2023
    Journal: International Journal of Biological Macromolecules
    DOI: 10.1016/j.ijbiomac.2023.124864
    ISSN: 0141-8130
  4. Title: Hydrogel Based on Nanoclay and Gelatin Methacrylate Polymeric Matrix as a Potential Osteogenic Application
    Authors: Danielle B. Andrade; Leticya L. S. Soares; Francisca L. A. Cardoso; Idglan S. Lima; Jhaemely G. V. Silva; Maria A. M. Carvalho; Maria Fonseca; Guilherme de C. Brito; Francisco Eroni Paz dos Santos; Josy Osajima et al.
    Year: 2023
    Journal: Journal of Functional Biomaterials
    DOI: 10.3390/jfb14020074
    ISSN: 2079-4983
  5. Title: Avanços Da Bioimpressão 3D Para A Medicina Regenerativa
    Authors: André Cardoso Tavares; Francisca Kaline Ferreira Pereira; Beatriz Lemos da Silva Loureiro; Evelle Rodrigues Sousa; Francisca Louenny Alves Cardoso
    Year: 2022
    Type: Conference abstract
  6. Title: O Uso De Células-Tronco Mesenquimais Como Tratamento Do Câncer E Sua Complexidade
    Authors: Francisca Kaline Ferreira Pereira; André Cardoso Tavares; Luísa Vitória de Sa Carneiro Souza; Francisca Louenny Alves Cardoso
    Year: 2022
    Type: Conference abstract
  7. Title: Uso De Células-Tronco Pluripotentes Induzidas Para Tratamento De Diabetes Mellitus
    Authors: Luísa Vitória de Sa Carneiro Souza; Paulo Renato de Oliveira Silva; Francisca Kaline Ferreira Pereira; Francisca Louenny Alves Cardoso
    Year: 2022
    Type: Conference abstract
  8. Title: Viabilidade Das Células-Tronco Mesenquimais Derivadas Da Medula Óssea Cultivadas Com Laponita
    Authors: Francisca Louenny Alves Cardoso; Danielle Benigno de Andrade e Silva; André Cardoso Tavares; Napoleão Martins Argolo Neto; Maria Acelina Martins De Carvalho
    Year: 2022
    Type: Conference abstract
  9. Title: Atividade Antifúngica Do Óleo Essencial De Cymbopogon Winterianus
    Authors: Francisco Vinicius Bezerra Oliveira; Francisca Louenny Alves Cardoso; Felipe de Carvalho Nunes; Sandiele Cantuario Sales; Tacyana Pires De Carvalho Costa; Kelly Maria Rêgo Da Silva
    Year: 2019
    Type: Conference abstract
  10. Title: Uso Da Nanopartícula De Laponita Para Diferenciação Celular Em Culturas De Células-Tronco Mesenquimais
    Authors: Francisca Louenny Alves Cardoso; Felipe de Carvalho Nunes; Francisco Vinicius Bezerra Oliveira; Pamela Benicio de Souza; Maryna De Oliveira Carneiro
    Year: 2019
    Type: Conference abstract

 

Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Dr. Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Assistant Professor of Mashhad university of Medical Sciences, Iran.

Dr. Ehsan Saburi is an Assistant Professor at the School of Medicine, Mashhad University of Medical Sciences, specializing in Molecular Medicine. He holds a Ph.D. and has contributed significantly to research in areas such as stem cell therapy, COVID-19, and the molecular mechanisms of various diseases. Dr. Saburi has led numerous research projects, exploring the genetic and molecular aspects of health conditions like COVID-19, cancer, and autoimmune disorders. His work includes the investigation of gene polymorphisms, the therapeutic potential of cell therapy, and the effects of natural compounds on disease progression. Dr. Saburi’s research has been published in high-impact journals, demonstrating his commitment to advancing medical knowledge. His expertise in molecular medicine and his dedication to innovative research make him a strong candidate for the Best Researcher Award.

Profile
Education

Dr. Ehsan Saburi is an accomplished academic with a strong foundation in Molecular Medicine. He earned his Doctor of Philosophy (Ph.D.) in this specialized field, reflecting his deep commitment to advancing medical science. His educational journey is marked by rigorous training and research, equipping him with a profound understanding of molecular mechanisms and their applications in medicine. Dr. Saburi’s academic background is further enriched by his involvement in various research projects at the Mashhad University of Medical Sciences, where he continues to explore the frontiers of medical research. His education has provided him with the skills and knowledge necessary to contribute significantly to the scientific community, particularly in the areas of stem cell research, genetic studies, and the development of innovative medical therapies. Dr. Saburi’s educational achievements underscore his dedication to excellence in both teaching and research, making him a respected figure in his field.

Professional Experience

Dr. Ehsan Saburi is an accomplished Assistant Professor at Mashhad University of Medical Sciences, specializing in Molecular Medicine. With a Ph.D. in the same field, he has played a pivotal role in various research projects, particularly those focusing on the molecular mechanisms of diseases, stem cell therapy, and the impact of genetic polymorphisms on health outcomes. His professional experience is marked by leadership in numerous high-impact studies, including investigations into COVID-19, stem cell differentiation, and the protective effects of natural compounds on organ systems. Dr. Saburi has been instrumental in advancing research in molecular medicine through his extensive work on genetic factors influencing disease severity and innovative therapeutic approaches. His contributions to the academic community are further evidenced by his numerous publications in reputable journals and his active involvement in ongoing research projects aimed at improving health outcomes through molecular and genetic insights.

Research Interest

Dr. Ehsan Saburi’s research interests lie at the intersection of molecular medicine and regenerative medicine, with a particular focus on the therapeutic potential of stem cells and the molecular mechanisms underlying various diseases. His work extensively explores the use of adipose-derived mesenchymal stem cells (AD-hMSCs) in tissue regeneration, particularly in the context of osteogenic and chondrogenic differentiation. Dr. Saburi is also deeply involved in studying the genetic and molecular pathways related to chronic diseases, including cancer and autoimmune disorders. His recent projects have investigated the effects of various bioactive compounds, such as melatonin and curcumin, on mitigating disease symptoms and improving patient outcomes. Additionally, Dr. Saburi’s research includes examining the genetic factors that influence the severity of infectious diseases like COVID-19, aiming to contribute to the development of more effective treatments and vaccines. His multidisciplinary approach positions him at the forefront of translational medicine and therapeutic innovation.

Research Skills

Dr. Ehsan Saburi, an Assistant Professor of Molecular Medicine at Mashhad University of Medical Sciences, demonstrates extensive expertise in advanced molecular and cellular research. His skills encompass a wide range of scientific techniques, including genetic manipulation, stem cell research, and biochemical analysis. Dr. Saburi has led numerous research projects, particularly focusing on the genetic and molecular mechanisms underlying diseases such as cancer, COVID-19, and neurodegenerative disorders. His proficiency in designing and executing complex experiments is evidenced by his successful investigation of various signaling pathways, gene polymorphisms, and therapeutic effects of natural compounds. Additionally, Dr. Saburi is skilled in the use of bioinformatics tools for data analysis and interpretation, contributing to his ability to publish in high-impact journals. His collaborative approach and ability to manage multidisciplinary research teams further highlight his research capabilities, making him a valuable asset in the field of molecular medicine.

Awards and Recognition

Dr. Ehsan Saburi, an accomplished Assistant Professor at Mashhad University of Medical Sciences, has garnered significant recognition for his contributions to molecular medicine. His extensive research on stem cell therapies, COVID-19, and the molecular mechanisms underlying various diseases has earned him numerous accolades. Dr. Saburi’s innovative work on the protective effects of melatonin and curcumin in disease models has been widely acknowledged in the scientific community. He has received several prestigious awards for his groundbreaking research, including the Best Researcher Award from Mashhad University. His publications in high-impact journals and his involvement in pioneering research projects have further solidified his reputation as a leading scientist. Dr. Saburi’s commitment to advancing medical science continues to be recognized through various honors and awards, underscoring his impact on the field and his dedication to improving human health.

Conclusion

Dr. Ehsan Saburi is a highly capable and dedicated researcher with significant contributions to molecular medicine and COVID-19 research. His extensive research activities, leadership in numerous projects, and commitment to advancing medical science make him a strong candidate for the Best Researcher Award. However, to enhance his candidacy further, focusing on the impact of his publications, fostering international collaborations, and pursuing more innovative research avenues would be beneficial.

Publications Top Notes

  1. Title: Advances and challenges of the cell-based therapies among diabetic patients
    Authors: Raoufinia, R., Rahimi, H.R., Saburi, E., Moghbeli, M.
    Journal: Journal of Translational Medicine
    Year: 2024
    Citations: 1
  2. Title: Leveraging stem cells to combat hepatitis: a comprehensive review of recent studies
    Authors: Raoufinia, R., Arabnezhad, A., Keyhanvar, N., Namdar, A.B., Rahimi, H.R.
    Journal: Molecular Biology Reports
    Year: 2024
  3. Title: Hematological changes due to malaria – An update
    Authors: Naser, R.H., Rajaii, T., Farash, B.R.H., Sadabadi, F., Saburi, E.
    Journal: Molecular and Biochemical Parasitology
    Year: 2024
  4. Title: Apoptotic effects of biodentine, calcium-enriched mixture (CEM) cement, ferric sulfate, and mineral trioxide aggregate (MTA) on human mesenchymal stem cells isolated from the human pulp of exfoliated deciduous teeth
    Authors: Nazemi Salman, B., Mohebbi Rad, M., Saburi, E.
    Journal: Minerva Dental and Oral Science
    Year: 2024
  5. Title: Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy
    Authors: Raoufinia, R., Rahimi, H.R., Keyhanvar, N., Foroudi, S., Saburi, E.
    Journal: Stem Cell Reviews and Reports
    Year: 2024
    Citations: 1
  6. Title: Role of microRNAs in tumor progression by regulation of kinesin motor proteins
    Authors: Nasimi Shad, A., Fanoodi, A., Maharati, A., Forouzanfar, F., Moghbeli, M.
    Journal: International Journal of Biological Macromolecules
    Year: 2024
  7. Title: Therapeutic potential of lipid-lowering probiotics on the atherosclerosis development
    Authors: Saadh, M.J., Bazghandi, B., Jamialahmdi, H., Esmaeili, S.-A., Saburi, E.
    Journal: European Journal of Pharmacology
    Year: 2024
  8. Title: Synthesis of bone biocompatible implants using human adipose-derived mesenchymal stem cells (hADMSCs) and PCL/laminin scaffold substrate
    Authors: Zeydari, D., Karimi, E., Saburi, E.
    Journal: Iranian Journal of Basic Medical Sciences
    Year: 2024
    Citations: 2
  9. Title: Genetic landscape of hearing loss in prelingual deaf patients of eastern Iran: Insights from exome sequencing analysis
    Authors: Alerasool, M., Eslahi, A., Vona, B., Niknezhad, H.T., Mojarrad, M.
    Journal: Clinical Genetics
    Year: 2024
  10. Title: Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics
    Authors: Raoufinia, R., Rahimi, H.R., Abbaszadeh, M., Khazaei, M., Avan, A.
    Journal: Current Pharmaceutical Design
    Year: 2024